Peer-reviewedLicence not statedFuture Oncology
Tissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma
5 affiliations
- 1Department of Zoology, Faculty of Science, Cairo University, Cairo, Egypt
- 2Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
- 3Faculty of Biotechnology, October University for Modern Science and Arts (MSA), Giza, Egypt
- 4Department of Clinical Pathology-Hematology and Ain Shams Medical Research Institute (MASRI), Faculty of Medicine, Ain Shams University, Cairo, Egypt
- 5Department of Burn, Plastic & Reconstructive Surgery, Skin Culture Lab, Al Nas Hospital, Cairo, Egypt
Related
- MicroRNAs expression changes associated with trauma-focused psychotherapy efficacy in treatment-resistant depression: An exploratory study
- Moesin emerges as a potential exploratory biomarker associated with renal fibrosis in diabetic kidney disease
- Intrafollicular PAI-1 Expression Is Associated with Absence of Histological Transformation During Long-Term Follow-Up in Follicular Lymphoma
- Pre-Treatment CD44 and CD47 Expression and Pathological Complete Response After Neoadjuvant Therapy in Breast Cancer: An Exploratory Single-Center Study
- The Challenges Associated with the Diagnosis and Treatment for Aplastic Anemia Concurrent with Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia
BibTeX
@article{hemdan2026tissuebased,
title = {{Tissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma}},
author = {Dina I. Hemdan and Salwa Sabet and Lobna Ezz El-Arab and Mohamed Alorabi and Haidan M. El-Shorbagy and Nashwa El-Khazragy},
journal = {Future Oncology},
year = {2026},
month = oct,
doi = {10.1080/14796694.2026.2739185},
url = {https://doi.org/10.1080/14796694.2026.2739185},
}
RIS
TY - JOUR
TI - Tissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma
AU - Dina I. Hemdan
AU - Salwa Sabet
AU - Lobna Ezz El-Arab
AU - Mohamed Alorabi
AU - Haidan M. El-Shorbagy
AU - Nashwa El-Khazragy
PY - 2026
DA - 2026/10/06
JO - Future Oncology
DO - 10.1080/14796694.2026.2739185
UR - https://doi.org/10.1080/14796694.2026.2739185
SN - 1479-6694
SN - 1744-8301
ER -